Get the Stockscreener App
23.02
1.50%
0.34
After Hours:
23.02
Integra Lifesciences Holdings Corp stock is traded at $23.02, with a volume of 361.07K.
It is up +1.50% in the last 24 hours and down -6.35% over the past month.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
See More
Previous Close:
$22.68
Open:
$22.88
24h Volume:
361.07K
Relative Volume:
0.48
Market Cap:
$1.78B
Revenue:
$1.53B
Net Income/Loss:
$40.23M
P/E Ratio:
19.02
EPS:
1.21
Net Cash Flow:
$60.93M
1W Performance:
+1.41%
1M Performance:
-6.35%
6M Performance:
-21.14%
1Y Performance:
-46.77%
1-Day Range:
$22.74
$23.20
1-Week Range:
$21.77
$23.20
52-Week Range:
$16.80
$45.42
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
Name
Integra Lifesciences Holdings Corp
Sector
Industry
Phone
(609) 275-0500
Address
1100 CAMPUS ROAD, PRINCETON, NJ
Compare IART with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
23.02 | 1.78B | 1.53B | 40.23M | 60.93M | 0.50 |
|
ABT
Abbott Laboratories
|
113.44 | 196.76B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
358.72 | 136.75B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
89.38 | 131.73B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
80.22 | 102.86B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
72.59 | 42.81B | 6.60B | 4.16B | 490.10M | 6.93 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-24 | Initiated | Morgan Stanley | Underweight |
| Oct-07-24 | Upgrade | BTIG Research | Sell → Neutral |
| Jul-30-24 | Downgrade | BTIG Research | Neutral → Sell |
| Jul-30-24 | Downgrade | Citigroup | Neutral → Sell |
| May-07-24 | Downgrade | Oppenheimer | Outperform → Perform |
| May-07-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-03-24 | Upgrade | Citigroup | Sell → Neutral |
| Dec-05-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-14-23 | Initiated | CL King | Buy |
| Aug-24-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jul-12-23 | Upgrade | Jefferies | Hold → Buy |
| Jun-08-23 | Downgrade | Argus | Buy → Hold |
| May-24-23 | Downgrade | JP Morgan | Neutral → Underweight |
| May-23-23 | Downgrade | Citigroup | Neutral → Sell |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-25-22 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Dec-17-21 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-15-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-08-20 | Downgrade | JP Morgan | Neutral → Underweight |
| May-27-20 | Initiated | Citigroup | Neutral |
| Apr-03-20 | Initiated | SunTrust | Buy |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-03-19 | Initiated | SunTrust | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Aug-07-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-26-18 | Upgrade | BTIG Research | Neutral → Buy |
| Jul-02-18 | Downgrade | Citigroup | Buy → Neutral |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Neutral |
| Jan-02-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Nov-09-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-30-17 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Oct-27-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| May-02-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jan-13-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jan-06-17 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Dec-12-16 | Initiated | UBS | Buy |
View All
Integra Lifesciences Holdings Corp Stock (IART) Latest News
Geode Capital Management LLC Sells 3,854 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Insider Stock Buying Reaches US$2.50m On Integra LifeSciences Holdings - Yahoo Finance
Here’s Why Integra LifeSciences Holdings Corporation (IART) Fell in Q3 - Yahoo Finance
Integra LifeSciences sets new executive severance terms - Investing.com
Comparing Integra LifeSciences (NASDAQ:IART) and Alpha Tau Medical (NASDAQ:DRTS) - Defense World
Fmr LLC Trims Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Advanced Wound Care Management Market Share to Rise At 5.1% CAGR, To Reach USD 17.50 Billion by 2034 | PMR - GlobeNewswire Inc.
Integra LifeSciences Holdings Co. (NASDAQ:IART) Given Consensus Recommendation of “Reduce” by Brokerages - Defense World
Sachem Head Capital Management LP Makes New Investment in Integra LifeSciences Holdings Co. (NASDAQ:IART) - MarketBeat
Integra LifeSciences EVP Eric Schwartz sells $100,101 in stock By Investing.com - Investing.com Nigeria
Integra LifeSciences EVP Eric Schwartz sells $100,101 in stock - Investing.com India
Insider Sell Alert: Eric Schwartz Sells Shares of Integra Lifesc - GuruFocus.com
Insider Sell: Michael Mcbreen Sells Shares of Integra Lifescienc - GuruFocus.com
Thrivent Financial for Lutherans Trims Stock Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Bridgewater Associates LP Sells 83,807 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - MarketBeat
Walleye Capital LLC Increases Stake in Integra LifeSciences Holdings Co. (NASDAQ:IART) - MarketBeat
Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Bought by Quantbot Technologies LP - MarketBeat
Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Sold by Victory Capital Management Inc. - Defense World
Rubric Capital Management LP Purchases New Shares in Integra LifeSciences Holdings Co. (NASDAQ:IART) - MarketBeat
Regenerative Medicine Market to grow by USD 70.11 Billion (2024-2028), rising prevalence of chronic diseases to drive revenue, Report with AI-powered insightsTechnavio - The Malaysian Reserve
IART Stock to Gain From New Study Findings on DuraSeal Dural Sealant - Yahoo Finance
Integra Lifesciences (IART) Stock Dips Amid Financial Concerns - GuruFocus.com
Integra’s DuraSeal® Dural Sealant Saves Healthcare Costs According to an Economic Evaluation Published in the Journal of Comparative Effectiveness Research - Yahoo Finance
Fuller & Thaler Asset Management, Inc. Expands Stake in Integra Lifesciences Holdings Corp - GuruFocus.com
Capital Research Global Investors Reduces Stake in Integra Lifes - GuruFocus.com
Integra LifeSciences Holdings Co. (NASDAQ:IART) Given Consensus Rating of "Reduce" by Analysts - MarketBeat
Integra LifeSciences : Serving Those Who Served - Marketscreener.com
Easterly Investment Partners LLC Has $1.12 Million Stock Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART) - MarketBeat
Leeward Investments LLC MA Has $6.83 Million Stock Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART) - MarketBeat
Integra Lifesciences (IART) Stock Sees Sharp 5.09% Decline Amid Market Fluctuations - GuruFocus.com
Olstein Capital Management L.P. Has $2.82 Million Stake in Integra LifeSciences Holdings Co. (NASDAQ:IART) - MarketBeat
Wound Dressing Market: Size, Share, Trends, and Global Analysis - openPR
Integra LifeSciences price target raised to $22 from $16 at Citi - Yahoo Finance
Louisiana State Employees Retirement System Sells 2,200 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
IART (Integra Lifesciences Holdings) PE Ratio without NRI : 8.77 (As of Nov. 05, 2024) - GuruFocus.com
Integra Q3 Earnings, Revenues Beat, Stock Up Despite Margin Pressure - MSN
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q3 2024 Earnings Call Transcript - Insider Monkey
Integra LifeSciences Holdings Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Integra Lifesciences Holdings Corp (IART) Q3 2024 Earnings Call - GuruFocus.com
Earnings call: Integra LifeSciences reports Q3 revenue decline, new CEO By Investing.com - Investing.com South Africa
Earnings call: Integra LifeSciences reports Q3 revenue decline, new CEO - Investing.com
Integra Lifesciences Holdings Corp (IART) Q3 2024 Earnings Call Highlights: Navigating ... - Yahoo Finance
Integra Lifesciences names Mojdeh Poul as CEO - Yahoo Finance
Citi raises Integra LifeSciences target to $22, maintains sell rating - Investing.com
Why Is Integra LifeSciences Stock Soaring On Monday? - Yahoo Finance
Integra LifeSciences (NASDAQ:IART) Shares Gap UpHere's What Happened - MarketBeat
Integra Lifesciences Holdings Corp (IART) Shares Up 25.16% on No - GuruFocus.com
Q3 2024 Integra Lifesciences Holdings Corp Earnings Call Transcript - GuruFocus.com
Integra LifeSciences (IART) Beats Q3 Earnings and Revenue Estimates - Yahoo Canada Finance
Integra: Q3 Earnings Snapshot - San Antonio Express-News
Integra Lifesciences Q3 Earnings: Revenue Beats at $380.8M, GAAP EPS Misses at $(0.14) - GuruFocus.com
Integra Lifesciences Holdings Corp Stock (IART) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.51%
0.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):